Sinus venosus atrial septal defect (SVASD) accounts for 5-10% of all ASDs. Partial anomalous pulmonary venous connection (PAPVC) and pulmonary hypertension (PH) in patients with SVASD increases the risk for surgical or transcatheter intervention. Closure is preferred over medical therapy. Transcatheter closure is challenging due to complex anatomy, difficulty in evaluating suitability for intervention, and lack of dedicated devices. We present a systematic approach using multimodality imaging and 3D printing for transcatheter closure of superior SVASD with PAPVC using a custom-made CP Stent®. A 53-year-old with history of drug abuse presented with NYHA Class III symptoms, hypoxemia, atrial flutter, and PH (MPAP of 30 mmHg) requiring multidrug therapy. Echocardiogram raised suspicion of superior SVASD, confirmed by cardiac CT and CMR. Multidisciplinary team ruled out surgery due to high risk and recommended transcatheter closure, if feasible. CT and CMR demonstrated a 20 × 18 mm superior SVASD with PAPVC: right upper (RUPV) and middle pulmonary veins draining into the superior vena cava (SVC). To understand spatial relationships, a 3D model was printed with 1.5-mm transparent and flexible walls to deploy a nonsterile prototype of the stent in the SVC. Rotational angiogram was performed to test feasibility of in-vivo deployment in view of stent foreshortening (from 110 to 70 mm) and differential widening of the SVC: 23 mm at the junction of the innominate vein; 35 mm at the atrial end. Transcatheter closure of superior SVASD with PAPVC in patients with PH is feasible in suitable cases using a systematic approach with multi-modality imaging and 3D printing.
right-to-left shunting across the ASD. He was cardioverted to normal sinus rhythm after ruling out intracardiac thrombus with transesophageal echocardiogram; oxygen saturation improved from 80 to 88%. Anti-PH therapy was initiated with macitentan and sildenafil. Cardiac computed tomography (CT) (Fig. 1a, b ) and cardiac magnetic resonance (CMR) demonstrated a 20 × 18 mm superior SVASD with partial anomalous pulmonary venous connection (PAPVC). In addition, CMR and CT demonstrated a severely dilated right ventricle (RV) with severely decreased systolic function ( Table 1 ). The interventricular septum was bowing into the left ventricle, consistent with increased preload in the RV and elevated right heart pressure ( Fig. 2a-c) . The right upper and middle pulmonary veins joined to form a confluence shortly before draining into the superior vena cava (SVC). Due to cardiac dysfunction and PH, surgical closure was considered to be high risk, and a multidisciplinary team recommended evaluation for transcatheter closure.
A three-dimensional (3D) model segmented from CMR (Supplementary Material 1) was printed in a flexible and transparent material for optimal visualization and simulation of human tissue characteristics, and for better understanding of the spatial relationships of the defect and surrounding anatomy (Fig. 3) . The model confirmed the design for the 10-zig custom-made covered Cheatham-platinum (CP) Stent® (NuMED, Inc., Hopkinton, NY). A prototype of the stent was deployed in the 3D-printed model, which confirmed feasibility for transcatheter closure of the defect (Fig. 4a-c ).
Cardiac catheterization with complete intra-cardiac hemodynamic assessment was performed to confirm preserved pulmonary vascular reactivity. Using pre- 5 ). Anatomic assessment using cone-beam CT was performed and coregistered with the pre-procedure CT angiogram ( Fig. 6 ) allowing for overlay of the 3D ROI onto the live 2D fluoroscopy. The fusion imaging helped in planning in vivo positioning of the CP stent for deployment. Rotational angiogram was performed to test feasibility of in vivo deployment in anticipation of stent foreshortening (from 110 to 70 mm) and differential widening of the SVC (23 mm at the junction of the innominate vein and 35 mm at the atrial end). Subsequently, transseptal puncture was performed for RUPV access and allowed for wire positioning without going through the SVASD. A 22F sheath was positioned in the SVC via left femoral access. The CP stent was advanced into the intended position over an Amplatzer superstiff 0.035-inch wire ( Fig. 7) with initial inflation of the inner balloon. A 12-mm PowerFlex balloon was then inflated to protect the RUPV prior to inflation of the outer balloon for CP stent deployment (Fig. 8 ). Post-procedure angiogram showed a well-seated stent covering the defect without residual shunting ( The physiologic effect of SVASD closure resulted in decrease in right atrium and RV size and normal exercise capacity in line with patient report of significant symptomatic improvement without recurrent atrial arrhythmias or oxygen requirement, and tolerating weaning of PH medication therapy. 
Discussion
SVASD accounts for 5-10% of all ASDs and is often diagnosed in adulthood when patients are found to have dilated right heart or become symptomatic following development of PH [1, 2] . SVASD is commonly associated with PAPVC of the RUPV. Adults with undiagnosed SVASD have higher incidence of PH and at a younger age due to the degree and duration of high pulmonary blood flow [1] . Closure decreases overall morbidity and mortality compared to medical therapy in patients with reversible PH [2] . SVASD is primarily closed surgically as transcatheter closure remains challenging. This is due to the complex anatomy, difficulty in evaluating suitability for intervention, and lack of dedicated devices [3, 4] . We demonstrated transcatheter closure of superior SVASD with PAPVC in a patient who was not a suitable candidate for surgical closure. This case emphasizes the importance of using a systematic approach with multi-modality imaging and 3D Fig. 4 A non-sterile prototype of the custom-made covered CP Stent was deployed in the 3Dprinted model to confirm feasibility for transcatheter closure of the defect Fig. 5 The region of interest was electronically marked on pre-procedure CT angiogram including the SVASD, RUPV, proximal and distal end of the SVC, and the azygos vein printing, which enabled us to avoid using anchoring hooks or active fixation barbs [4] that have the potential to erode adjoining structures. Anatomical features important in ensuring successful transcatheter closure of SVASD with PAPVR include (1) posterolateral alignment with the pulmonary arteries, (2) ability to accommodate an adult sized stent, and (3) an anchoring zone in the SVC that does not obstruct the innominate vein or other blood vessels. In our patient, we performed transseptal puncture to ensure patency of pulmonary venous drainage into the LA as any degree of obstruction to the pulmonary veins can lead to progressive PH. Our approach also provides the option to create an atrial fenestration to manage potential PH crisis.
Although a case series of four patients with follow-up period ranging from 4 to 6 years describes safe and feasible transcatheter SVASD closure [5] , future studies in a larger cohort of patients are required to evaluate the long-term outcomes of surgical vs. transcatheter closure of SVASD, including those with evidence of PH with preserved pulmonary vascular vasoreactivity.
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